BridgeBio Pharma (BBIO) Dividends Paid - Common (2019)

BridgeBio Pharma (BBIO) posted Dividends Paid - Common of $54.0 million for Q4 2019, up 5317.65% sequentially from $997000.0 in Q1 2019.

BridgeBio Pharma (BBIO) Dividends Paid - Common (2019) Analysis & Trends

BridgeBio Pharma has reported Dividends Paid - Common for 1 years, with the latest figure at $54.0 million in Q4 2019.

Quarterly Dividends Paid - Common changed N/A year-over-year to $54.0 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $55.0 million (changed N/A YoY) and the FY2020 annual result came in at $5.0 million, down 90.91% from the prior year.
Dividends Paid - Common rose to $54.0 million in Q4 2019 per BBIO's latest filing, from $997000.0 in the prior quarter.
Over five years, Dividends Paid - Common peaked at $54.0 million in Q4 2019 and troughed at $997000.0 in Q1 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Dividends Paid - Common (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	96.80 Mn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	-
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	34.60 Mn
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-
10	BridgeBio Pharma	15.60 Bn	14.89 Bn	228.63 Mn	-

Download Data